Analystreport

Jounce Therapeutics Inc (NASDAQ: JNCE) was given a new $13.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Jounce Therapeutics, Inc.  (JNCE) 
Last jounce therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.jouncetx.com